Texas Man Suffered Risperdal Gynecomastia after Taking Drug for ADHD, Lawsuit Alleges

Published on February 17, 2015 by Laurie Villanueva

Text-Size:A A A+


A Risperdal lawsuit has been filed in Texas by a man who alleges gynecomastia and other complications caused by the antipsychotic medication, court documents indicate.

According to recent reports, the case was brought to Jefferson County District Court on November 21, 2014 and involves an individual who was prescribed the drug for his ADHD.  Upon starting treatment with the medication, the man allegedly suffered long-lasting emotional problems and Risperdal gynecomastia, a condition referring to the development of male breasts. The plaintiff in this case started taking Risperdal at the age of 7, at a time when the U.S. Food and Drug Administration (FDA) had not approved its use for children, and had only been cleared for adults and adolescents with schizophrenia and bipolar disorder.

It wasn’t until 2006 that the federal agency updated Risperdal’s label information to include the treatment of irritability symptoms in children with autism. Even after that, ADHD was not listed as a specified use for this medication by the FDA, so the boy’s prescription could be considered off-label as well.

Philadelphia Litigation Includes Nearly 1,300 Risperdal Lawsuits

Claims included in this individual’s lawsuit are similar to nearly 1,300 others now filed in the Philadelphia Court of Common Pleas. There, a consolidated proceeding has been centralized for lawsuits that similarly allege gynecomastia and other complications of the antipsychotic drug. According to court documents, at least 1,270 claims are now included in the Pennsylvania litigation. Many of these include allegations of breast growth that resulted in the need for mastectomy and liposuction procedures, and manifested in lactation, as well as swollen breasts.

Individuals whose Risperdal lawsuits are now filed in Philadelphia also allege Johnson & Johnson and Janssen’s off-label promotion of the drug for uses not approved by the FDA. Similar claims have not only been filed in state court, though. They were also alleged in charges brought by the U.S. Department of Justice that were resolved in November 2013 with the drug manufacturer’s payment of $2.5 billion.

According to the federal government, this settlement represented one of the largest in the U.S. District Court, Eastern District of Pennsylvania’s history.

Call a Risperdal Lawyer

Risperdal lawsuits now pending in Philadelphia state court seek compensation for out-of-pocket medical expenses, lost wages, pain and suffering and other issues that followed use of the antipsychotic medication. Call our Firm to file a case that seeks retribution for other damages:.